{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:31:16Z","timestamp":1770744676277,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["Project No. 007491"],"award-info":[{"award-number":["Project No. 007491"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["Project CENTRO-01-0145-FEDER-000013"],"award-info":[{"award-number":["Project CENTRO-01-0145-FEDER-000013"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["Project UID\/Multi \/00709"],"award-info":[{"award-number":["Project UID\/Multi \/00709"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00277-018-3332-7","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T04:50:27Z","timestamp":1526964627000},"page":"1563-1575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Distinctive CD8+ T cell and MHC class I signatures in polycythemia vera patients"],"prefix":"10.1007","volume":"97","author":[{"given":"Elsa M.","family":"Cardoso","sequence":"first","affiliation":[]},{"given":"Andr\u00e9 J.","family":"Esgalhado","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Patr\u00e3o","sequence":"additional","affiliation":[]},{"given":"M\u00f3nica","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Vasco Pinto","family":"Neves","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Martinez","sequence":"additional","affiliation":[]},{"given":"Maria Assun\u00e7\u00e3o Vaz","family":"Patto","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Fernando A.","family":"Arosa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"issue":"20","key":"3332_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405","journal-title":"Blood"},{"key":"3332_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.95","volume":"5","author":"S Cerquozzi","year":"2015","unstructured":"Cerquozzi S, Tefferi A (2015) Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J 5:e366","journal-title":"Blood Cancer J"},{"issue":"1","key":"3332_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3324\/haematol.2015.129155","volume":"102","author":"AM Vannucchi","year":"2017","unstructured":"Vannucchi AM (2017) From leeches to personalized medicine: evolving concepts in the management of polycythemia vera. Haematologica 102(1):18\u201329","journal-title":"Haematologica"},{"issue":"5","key":"3332_CR4","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1158\/1078-0432.CCR-15-0905","volume":"22","author":"AB Patel","year":"2016","unstructured":"Patel AB, Vellore NA, Deininger MW (2016) New strategies in myeloproliferative neoplasms: the evolving genetic and therapeutic landscape. Clin Cancer Res 22(5):1037\u20131047","journal-title":"Clin Cancer Res"},{"issue":"8","key":"3332_CR5","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2008-03-143537","volume":"112","author":"JJ Kiladjian","year":"2008","unstructured":"Kiladjian JJ, Cassinat B, Chevret S, Turlure P, Cambier N, Roussel M, Bellucci S, Grandchamp B, Chomienne C, Fenaux P (2008) Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera. Blood 112(8):3065\u20133072","journal-title":"Blood"},{"key":"3332_CR6","doi-asserted-by":"crossref","unstructured":"Quint\u00e1s-Cardama A, Abdel-Wahab O, Manshouri T, Kilpivaara O, Cortes J, Roupie AL, Zhang SJ, Harris D, Estrov Z, Kantarjian H, Levine RL, Verstovsek S (2013) Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon \u03b1-2a. Blood 122(6):893\u2013901","DOI":"10.1182\/blood-2012-07-442012"},{"issue":"5","key":"3332_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1600-0609.1983.tb02536.x","volume":"30","author":"S Eridani","year":"1983","unstructured":"Eridani S, Fiorini GF, Batten E (1983) Peripheral blood lymphocyte subpopulations in polycythaemia and thrombocythaemia. Scand J Haematol 30(5):479\u2013485","journal-title":"Scand J Haematol"},{"issue":"2","key":"3332_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/jcp.40.2.206","volume":"40","author":"JT Wilde","year":"1987","unstructured":"Wilde JT, Barnett D, Forrest MJ, Lawrence AC (1987) Peripheral blood lymphocyte subpopulations in patients with primary proliferative and secondary polycythaemia. J Clin Pathol 40(2):206\u2013209","journal-title":"J Clin Pathol"},{"issue":"1","key":"3332_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000205159","volume":"83","author":"F Rueda","year":"1990","unstructured":"Rueda F, Remacha A, Mart\u00ed F, Pi\u00f1ol G, Soler J, Gua\u00f1abens C, Gimferrer E (1990) Different lymphocyte activity in patients with polycythaemia vera versus secondary polycythaemia and healthy blood donors. Acta Haematol 83(1):31\u201334","journal-title":"Acta Haematol"},{"issue":"18","key":"3332_CR10","first-page":"1781","volume":"121","author":"WB Zhao","year":"2008","unstructured":"Zhao WB, Li Y, Liu X, Zhang LY, Wang X (2008) Involvement of CD4+CD25+ regulatory T cells in the pathogenesis of polycythaemia vera. Chin Med J(Engl) 121(18):1781\u20131786","journal-title":"Chin Med J(Engl)"},{"issue":"8","key":"3332_CR11","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1182\/blood-2011-03-340992","volume":"118","author":"CH Riley","year":"2011","unstructured":"Riley CH, Jensen MK, Brimnes MK, Hasselbalch HC, Bjerrum OW, Straten PT, Svane IM (2011) Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-\u03b1. Blood 118(8):2170\u20132173","journal-title":"Blood"},{"issue":"3","key":"3332_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bcmd.2015.06.005","volume":"55","author":"AR Costa-Brito","year":"2015","unstructured":"Costa-Brito AR, Cardoso EM, Martinez J, Arosa FA (2015) The JAK2V617F mutation is associated with anomalies in the frequency of monocytes, B cells, CD8+ T cells and NK cells. Blood Cells Mol Dis 55(3):208\u2013210","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"3332_CR13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.humimm.2015.03.021","volume":"76","author":"C Sanchez","year":"2015","unstructured":"Sanchez C, Le Treut T, Baier C, S\u00e9bahoun G, Costello RT (2015) Distribution of lymphocyte subpopulations in patients with polycythemia vera. Hum Immunol 76(6):414\u2013416","journal-title":"Hum Immunol"},{"issue":"1","key":"3332_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/ejh.12687","volume":"97","author":"CH Riley","year":"2016","unstructured":"Riley CH, Brimnes MK, Hansen M, Jensen MK, Hasselbalch HC, Kjaer L, Straten PT, Svane IM (2016) Interferon-\u03b1 induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia vera. Eur J Haematol 97(1):83\u201392","journal-title":"Eur J Haematol"},{"key":"3332_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40164-016-0057-y","volume":"5","author":"M Kovacsovics-Bankowski","year":"2016","unstructured":"Kovacsovics-Bankowski M, Kelley TW, Efimova O, Kim SJ, Wilson A, Swierczek S, Prchal J (2016) Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with JAK2V617F allelic burden. Exp Hematol Oncol 5:28","journal-title":"Exp Hematol Oncol"},{"issue":"10","key":"3332_CR16","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3109\/10428194.2013.764417","volume":"54","author":"V Skov","year":"2013","unstructured":"Skov V, Riley CH, Thomassen M, Larsen TS, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC (2013) Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis. Leuk Lymphoma 54(10):2269\u20132273","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"3332_CR17","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1080\/10428194.2016.1262032","volume":"58","author":"V Skov","year":"2017","unstructured":"Skov V, Riley CH, Thomassen M, Kj\u00e6r L, Stauffer Larsen T, Bjerrum OW, Kruse TA, Hasselbalch HC (2017) The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms. Leuk Lymphoma 58(8):1914\u20131921","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"3332_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1056\/NEJMoa1409002","volume":"372","author":"AM Vannucchi","year":"2015","unstructured":"Vannucchi AM, Kiladjian JJ, Griesshammer M, Masszi T, Durrant S, Passamonti F, Harrison CN, Pane F, Zachee P, Mesa R, He S, Jones MM, Garrett W, Li J, Pirron U, Habr D, Verstovsek S (2015) Ruxolitinib versus standard therapy for the treatment of polycythemia vera. N Engl J Med 372(5):426\u2013435","journal-title":"N Engl J Med"},{"issue":"2","key":"3332_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/leu.2013.296","volume":"28","author":"M Massa","year":"2014","unstructured":"Massa M, Rosti V, Campanelli R, Fois G, Barosi G (2014) Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib. Leukemia 28(2):449\u2013451","journal-title":"Leukemia"},{"issue":"11","key":"3332_CR20","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-14-3198","volume":"75","author":"K Sch\u00f6nberg","year":"2015","unstructured":"Sch\u00f6nberg K, Rudolph J, Vonnahme M, Parampalli Yajnanarayana S, Cornez I, Hejazi M, Manser AR, Uhrberg M, Verbeek W, Koschmieder S, Br\u00fcmmendorf TH, Brossart P, Heine A, Wolf D (2015) JAK inhibition impairs NK cell function in myeloproliferative neoplasms. Cancer Res 75(11):2187\u20132199","journal-title":"Cancer Res"},{"issue":"3","key":"3332_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.it.2007.01.002","volume":"28","author":"FA Arosa","year":"2007","unstructured":"Arosa FA, Santos SG, Powis SJ (2007) Open conformers: the hidden face of MHC-I molecules. Trends Immunol 28(3):115\u2013123","journal-title":"Trends Immunol"},{"issue":"10","key":"3332_CR22","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.4049\/jimmunol.0802470","volume":"182","author":"MP Correia","year":"2009","unstructured":"Correia MP, Cardoso EM, Pereira CF, Neves R, Uhrberg M, Arosa FA (2009) Hepatocytes and IL-15: a favorable microenvironment for T cell survival and CD8+ T cell differentiation. J Immunol 182(10):6149\u20136159","journal-title":"J Immunol"},{"issue":"51","key":"3332_CR23","doi-asserted-by":"publisher","first-page":"53062","DOI":"10.1074\/jbc.M408794200","volume":"279","author":"SG Santos","year":"2004","unstructured":"Santos SG, Powis SJ, Arosa FA (2004) Misfolding of major histocompatibility complex class I molecules in activated T cells allows cis-interactions with receptors and signaling molecules and is associated with tyrosine phosphorylation. J Biol Chem 279(51):53062\u201353070","journal-title":"J Biol Chem"},{"issue":"3","key":"3332_CR24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bbi.2007.09.001","volume":"22","author":"JP Campbell","year":"2008","unstructured":"Campbell JP, Guy K, Cosgrove C, Florida-James GD, Simpson RJ (2008) Total lymphocyte CD8 expression is not a reliable marker of cytotoxic T-cell populations in human peripheral blood following an acute bout of high-intensity exercise. Brain Behav Immun 22(3):375\u2013380","journal-title":"Brain Behav Immun"},{"key":"3332_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3389\/fimmu.2016.00665","volume":"7","author":"FA Arosa","year":"2017","unstructured":"Arosa FA, Esgalhado AJ, Padr\u00e3o CA, Cardoso EM (2017) Divide, conquer, and sense: CD8+CD28- T cells in perspective. Front Immunol 7:665","journal-title":"Front Immunol"},{"issue":"11","key":"3332_CR26","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/ajh.23295","volume":"87","author":"R Vaidya","year":"2012","unstructured":"Vaidya R, Gangat N, Jimma T, Finke CM, Lasho TL, Pardanani A, Tefferi A (2012) Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis. Am J Hematol 87(11):1003\u20131005","journal-title":"Am J Hematol"},{"key":"3332_CR27","doi-asserted-by":"publisher","first-page":"102476","DOI":"10.1155\/2015\/102476","volume":"2015","author":"HC Hasselbalch","year":"2015","unstructured":"Hasselbalch HC, Bj\u00f8rn ME (2015) MPNs as inflammatory diseases: the evidence, consequences, and perspectives. Mediat Inflamm 2015:102476","journal-title":"Mediat Inflamm"},{"issue":"2","key":"3332_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.leukres.2012.10.020","volume":"37","author":"HC Hasselbalch","year":"2013","unstructured":"Hasselbalch HC (2013) Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development? Leuk Res 37(2):214\u2013220","journal-title":"Leuk Res"},{"issue":"10","key":"3332_CR29","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1002\/eji.201040404","volume":"40","author":"S Mumprecht","year":"2010","unstructured":"Mumprecht S, Sch\u00fcrch C, Scherrer S, Claus C, Ochsenbein AF (2010) Chronic myelogenous leukemia maintains specific CD8+ T cells through IL-7 signaling. Eur J Immunol 40(10):2720\u20132730","journal-title":"Eur J Immunol"},{"issue":"2","key":"3332_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/cdd.2014.89","volume":"22","author":"C Riether","year":"2015","unstructured":"Riether C, Sch\u00fcrch CM, Ochsenbein AF (2015) Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ 22(2):187\u2013198","journal-title":"Cell Death Differ"},{"issue":"2","key":"3332_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/imm.12600","volume":"148","author":"Y Vuddamalay","year":"2016","unstructured":"Vuddamalay Y, Attia M, Vicente R, Pomi\u00e9 C, Enault G, Leobon B, Joffre O, Romagnoli P, van Meerwijk JP (2016) Mouse and human CD8(+)CD28(low) regulatory T lymphocytes differentiate in the thymus. Immunology 148(2):187\u2013196","journal-title":"Immunology"},{"issue":"1","key":"3332_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1084\/jem.187.1.89","volume":"187","author":"KR Ryan","year":"1998","unstructured":"Ryan KR, Evavold BD (1998) Persistence of peptide-induced CD4+ T cell anergy in vitro. J Exp Med 187(1):89\u201396","journal-title":"J Exp Med"},{"issue":"2","key":"3332_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/leu.2016.290","volume":"31","author":"MO Holmstr\u00f6m","year":"2017","unstructured":"Holmstr\u00f6m MO, Hjorts\u00f8 MD, Ahmad SM, Met \u00d6, Martinenaite E, Riley C, Straten P, Svane IM, Hasselbalch HC, Andersen MH (2017) The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms. Leukemia 31(2):495\u2013498","journal-title":"Leukemia"},{"issue":"7","key":"3332_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0145-2126(89)90119-7","volume":"13","author":"KH Nocka","year":"1989","unstructured":"Nocka KH, Ottman OG, Pelus LM (1989) The role of marrow accessory cell populations in the augmentation of human erythroid progenitor cell (BFU-E) proliferation by prostaglandin E. Leuk Res 13(7):527\u2013534","journal-title":"Leuk Res"},{"issue":"4","key":"3332_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1365-2141.2007.06737.x","volume":"139","author":"S Li","year":"2007","unstructured":"Li S, Wang L, Zhao C, Li L, Peng J, Hou M (2007) CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura. Br J Haematol 139(4):605\u2013611","journal-title":"Br J Haematol"},{"issue":"1","key":"3332_CR36","doi-asserted-by":"publisher","first-page":"e02493-e025014","DOI":"10.1128\/mBio.02493-14","volume":"6","author":"I Safeukui","year":"2015","unstructured":"Safeukui I, Gomez ND, Adelani AA, Burte F, Afolabi NK, Akondy R, Velazquez P, Holder A, Tewari R, Buffet P, Brown BJ, Shokunbi WA, Olaleye D, Sodeinde O, Kazura J, Ahmed R, Mohandas N, Fernandez-Reyes D, Haldar K (2015) Malaria induces anemia through CD8+ T cell-dependent parasite clearance and erythrocyte removal in the spleen. MBio 6(1):e02493-e025014","journal-title":"MBio"},{"key":"3332_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/srep27445","volume":"6","author":"J Qiu","year":"2016","unstructured":"Qiu J, Liu X, Li X, Zhang X, Han P, Zhou H, Shao L, Hou Y, Min Y, Kong Z, Wang Y, Wei Y, Liu X, Ni H, Peng J, Hou M (2016) CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia. Sci Rep 6:27445","journal-title":"Sci Rep"},{"issue":"9","key":"3332_CR38","first-page":"1370","volume":"7","author":"A Cassel","year":"1993","unstructured":"Cassel A, Braester A, Quitt M, Froom P, Aghai E (1993) Soluble factors from peripheral blood T-cells of patients with polycythemia vera stimulate normal BFU-E. Leukemia 7(9):1370\u20131373","journal-title":"Leukemia"},{"issue":"6","key":"3332_CR39","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood.V92.6.1967","volume":"92","author":"K Geissler","year":"1998","unstructured":"Geissler K, Ohler L, F\u00f6dinger M, Kabrna E, Kollars M, Skoupy S, Lechner K (1998) Interleukin-10 inhibits erythropoietin-independent growth of erythroid bursts in patients with polycythemia vera. Blood 92(6):1967\u20131972","journal-title":"Blood"},{"issue":"12","key":"3332_CR40","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1038\/sj.leu.2404899","volume":"21","author":"T Ishii","year":"2007","unstructured":"Ishii T, Zhao Y, Shi J, Sozer S, Hoffman R, Xu M (2007) T cells from patients with polycythemia vera elaborate growth factors which contribute to endogenous erythroid and megakaryocyte colony formation. Leukemia 21(12):2433\u20132441","journal-title":"Leukemia"},{"key":"3332_CR41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.0105-2896.2005.00315.x","volume":"207","author":"TH Hansen","year":"2005","unstructured":"Hansen TH, Lybarger L, Yu L, Mitaksov V, Fremont DH (2005) Recognition of open conformers of classical MHC by chaperones and monoclonal antibodies. Immunol Rev 207:100\u2013111","journal-title":"Immunol Rev"},{"issue":"1","key":"3332_CR42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4049\/jimmunol.123.1.342","volume":"123","author":"P Parham","year":"1979","unstructured":"Parham P, Barnstable CJ, Bodmer WF (1979) Use of a monoclonal antibody (W6\/32) in structural studies of HLA-A,B,C, antigens. J Immunol 123(1):342\u2013349","journal-title":"J Immunol"},{"issue":"4","key":"3332_CR43","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s002510050498","volume":"49","author":"JJ Ladasky","year":"1999","unstructured":"Ladasky JJ, Shum BP, Canavez F, Seu\u00e1nez HN, Parham P (1999) Residue 3 of beta2-microglobulin affects binding of class I MHC molecules by the W6\/32 antibody. Immunogenetics 49(4):312\u2013320","journal-title":"Immunogenetics"},{"issue":"7","key":"3332_CR44","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.4049\/jimmunol.137.7.2299","volume":"137","author":"NJ Stam","year":"1986","unstructured":"Stam NJ, Spits H, Ploegh HL (1986) Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 137(7):2299\u20132306","journal-title":"J Immunol"},{"issue":"4","key":"3332_CR45","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.4049\/jimmunol.171.4.1918","volume":"171","author":"F Perosa","year":"2003","unstructured":"Perosa F, Luccarelli G, Prete M, Favoino E, Ferrone S, Beta DF (2003) 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. J Immunol 171(4):1918\u20131926","journal-title":"J Immunol"},{"issue":"11","key":"3332_CR46","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/rheumatology\/kel305","volume":"45","author":"T Raine","year":"2006","unstructured":"Raine T, Brown D, Bowness P, Hill Gaston JS, Moffett A, Trowsdale J, Allen RL (2006) Consistent patterns of expression of HLA class I free heavy chains in healthy individuals and raised expression in spondyloarthropathy patients point to physiological and pathological roles. Rheumatology (Oxford) 45(11):1338\u20131344","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3332_CR47","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2567.2007.02789.x","volume":"124","author":"R Apps","year":"2008","unstructured":"Apps R, Gardner L, Hiby SE, Sharkey AM, Moffett A (2008) Conformation of human leucocyte antigen-C molecules at the surface of human trophoblast cells. Immunology 124(3):322\u2013328","journal-title":"Immunology"},{"issue":"5","key":"3332_CR48","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1084\/jem.171.5.1431","volume":"171","author":"E Schnabl","year":"1990","unstructured":"Schnabl E, Stockinger H, Majdic O, Gaugitsch H, Lindley IJ, Maurer D, Hajek-Rosenmayr A, Knapp W (1990) Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin. J Exp Med 171(5):1431\u20131442","journal-title":"J Exp Med"},{"issue":"8","key":"3332_CR49","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00262-005-0085-7","volume":"55","author":"N Ramnath","year":"2006","unstructured":"Ramnath N, Tan D, Li Q, Hylander BL, Bogner P, Ryes L, Ferrone S (2006) Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival? Cancer Immunol Immunother 55(8):891\u2013899","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"3332_CR50","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1016\/S0021-9258(17)37430-6","volume":"269","author":"S Demaria","year":"1994","unstructured":"Demaria S, Schwab R, Gottesman SR, Bushkin Y (1994) Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J Biol Chem 269(9):6689\u20136694","journal-title":"J Biol Chem"},{"issue":"5","key":"3332_CR51","first-page":"966","volume":"29","author":"WC Tsai","year":"2002","unstructured":"Tsai WC, Chen CJ, Yen JH, Ou TT, Tsai JJ, Liu CS, Liu HW (2002) Free HLA class I heavy chain-carrying monocytes-a potential role in the pathogenesis of spondyloarthropathies. J Rheumatol 29(5):966\u2013972","journal-title":"J Rheumatol"},{"issue":"1","key":"3332_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2133.2004.05890.x","volume":"151","author":"CC Lan","year":"2004","unstructured":"Lan CC, Tsai WC, Wu CS, Yu CL, Yu HS (2004) Psoriatic patients with arthropathy show significant expression of free HLA class I heavy chains on circulating monocytes: a potential role in the pathogenesis of psoriatic arthropathy. Br J Dermatol 151(1):24\u201331","journal-title":"Br J Dermatol"},{"key":"3332_CR53","first-page":"259","volume-title":"Narinder K. Mehra. The HLA complex in biology and medicine. New Delhi, India: Jayppee brothers medical publishers","author":"MA Khan","year":"2010","unstructured":"Khan MA (2010) HLA and spondyloarthropathies. In: Narinder K. Mehra. The HLA complex in biology and medicine. New Delhi, India: Jayppee brothers medical publishers, pp 259\u2013275 ISBN 978-81-8448-870-8"},{"key":"3332_CR54","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fimmu.2016.00281","volume":"7","author":"LE Hudson","year":"2016","unstructured":"Hudson LE, Allen RL (2016) Leukocyte Ig-like receptors - a model for MHC class I disease associations. Front Immunol 7:281","journal-title":"Front Immunol"},{"issue":"7","key":"3332_CR55","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.4049\/jimmunol.1202926","volume":"190","author":"I Wong-Baeza","year":"2013","unstructured":"Wong-Baeza I, Ridley A, Shaw J, Hatano H, Rysnik O, McHugh K, Piper C, Brackenbridge S, Fernandes R, Chan A, Bowness P, Kollnberger S (2013) KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis. J Immunol 190(7):3216\u20133224","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"3332_CR56","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/ddr.21187","volume":"75","author":"A Cauli","year":"2014","unstructured":"Cauli A, Piga M, Dessole G, Porru G, Floris A, Vacca A, Desogus E, La Nasa G, Mathieu A (2014) Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis. Drug Dev Res 75(Suppl 1):S15\u2013S19","journal-title":"Drug Dev Res"},{"issue":"6","key":"3332_CR57","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.4049\/jimmunol.171.6.2945","volume":"171","author":"E Assa-Kunik","year":"2003","unstructured":"Assa-Kunik E, Fishman D, Kellman-Pressman S, Tsory S, Elhyany S, Baharir O, Segal S (2003) Alterations in the expression of MHC class I glycoproteins by B16BL6 melanoma cells modulate insulin receptor-regulated signal transduction and augment resistance to apoptosis. J Immunol 171(6):2945\u20132952","journal-title":"J Immunol"},{"issue":"2","key":"3332_CR58","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00262-006-0183-1","volume":"56","author":"CC Chang","year":"2007","unstructured":"Chang CC, Ferrone S (2007) Immune selective pressure and HLA class I antigen defects in malignant lesions. Cancer Immunol Immunother 56(2):227\u2013236","journal-title":"Cancer Immunol Immunother"},{"key":"3332_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1479-5876-7-59","volume":"7","author":"C Smith","year":"2009","unstructured":"Smith C, Santi M, Rajan B, Rushing EJ, Choi MR, Rood BR, Cornelison R, MacDonald TJ, Vukmanovic S (2009) A novel role of HLA class I in the pathology of medulloblastoma. J Transl Med 7:59","journal-title":"J Transl Med"},{"issue":"2","key":"3332_CR60","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11060-010-0378-3","volume":"103","author":"C Smith","year":"2011","unstructured":"Smith C, Santi M, Rushing EJ, Cornelison R, MacDonald TJ, Vukmanovic S (2011) Characterization of signaling function and expression of HLA class I molecules in medulloblastoma. J Neuro-Oncol 103(2):197\u2013206","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"3332_CR61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14712\/fb2004050020035","volume":"50","author":"D Fishman","year":"2004","unstructured":"Fishman D, Elhyany S, Segal S (2004) Non-immune functions of MHC class I glycoproteins in normal and malignant cells. Folia Biol (Praha) 50(2):35\u201342","journal-title":"Folia Biol (Praha)"},{"issue":"1","key":"3332_CR62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/embor.2008.215","volume":"10","author":"P Bowness","year":"2009","unstructured":"Bowness P, Caplan S, Edidin M (2009) MHC molecules lead many lives. Workshop on MHC class I molecules at the interface between Biology & Medicine. EMBO Rep 10(1):30\u201334","journal-title":"EMBO Rep"},{"issue":"2","key":"3332_CR63","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cels.2016.06.006","volume":"3","author":"CL Plaisier","year":"2016","unstructured":"Plaisier CL, O'Brien S, Bernard B, Reynolds S, Simon Z, Toledo CM, Ding Y, Reiss DJ, Paddison PJ, Baliga NS (2016) Causal mechanistic regulatory network for glioblastoma deciphered using systems genetics network analysis. Cell Syst 3(2):172\u2013186","journal-title":"Cell Syst"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3332-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T17:31:57Z","timestamp":1751650317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3332-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3332"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3332-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"3 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethic Committees of the three Hospitals approved the study and each subject gave written informed consent prior to enrolment in the study according to the Declaration of Helsinki. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}